We explore key research strategies and technologies applied to human antibody repertoires in the path to developing therapeutics and vaccines.
Profiling and identifying antibody repertoires is key to finding immune responses and desired therapeutic strategies. Different processes rapidly arose across the industry over the recent years, particularly in antibody discovery for COVID-19 vaccines.
In this ebook, we explore key research strategies and technologies applied to human antibody repertoires in the path to developing therapeutics and vaccines. We also look at screening processes, such as epitope mapping and next generation sequencing, which have enabled researchers to discover and optimize antibodies.
Biomedical researcher Dr Catarina Carrão explores the industry’s challenges and innovations so far, while biotech writer Olivia Siviter revisits top insights presented at recent Antibody Engineering & Therapeutics conferences.
Jump to any article using the contents on the following page, or at any time using the Contents menu in the top left. There you can also download this eBook as a PDF.
Dr Catarina Carrão explores the industry’s challenges and innovations so far
We look at the research of Dr Elaine Chen at Vanderbilt University School of Medicine
We explore the work of Dr Paul Utz at Stanford University School of Medicine
A whitepaper by Abveris
We look at novel approaches by Dr Andrew Ward at Scripps Research
We highlight insights from Dr Isidro Hotzel at Department of Antibody Engineering, Genentech
